Introduction:Basic information about CAS 52450-38-1|AFMK, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | AFMK |
|---|
| CAS Number | 52450-38-1 | Molecular Weight | 264.277 |
|---|
| Density | 1.2±0.1 g/cm3 | Boiling Point | 589.4±50.0 °C at 760 mmHg |
|---|
| Molecular Formula | C13H16N2O4 | Melting Point | 138-140ºC |
|---|
| MSDS | / | Flash Point | 310.3±30.1 °C |
|---|
Names
| Name | N-γ-Acetyl-N-2-formyl-5-methoxykynurenamine |
|---|
| Synonym | More Synonyms |
|---|
AFMK BiologicalActivity
| Description | AFMK, antioxidant metabolite of Melatonin, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. AFMK is a poorer scavenger. The pKa of AFMK at physiological pH is 8.7. Antioxidant capacity[1][2]. AFMK improves the anti-tumor effect of Gemcitabine in PANC-1 cells through the modulation of apoptotic pathway[3]. |
|---|
| Related Catalog | Research Areas >>Cancer |
|---|
| Target | Human Endogenous Metabolite |
|---|
| In Vitro | AFMK is one of the metabolites of melatonin and can be formed by both enzymatic or pseudoenzymatic and nonenzymatic metabolic pathways[1]. AFMK pretreatment significantly inhibits DNA damage. AFMK shows a very high level of in vitro hydroxyl radical scavenging potential which was measured by an electron spin resonance (ESR) study. IC50 values resulting from ESR analysis was 338.08 nM. AFMK, a melatonin metabolite, is a sparingly investigated biogenic amine[2]. AFMK administered to PANC-1 in combination with Gemcitabine inhibits the production of HSP70 and cIAP-2 as compared to the results obtained with Gemcitabine alone[3]. Western Blot Analysis[3] Cell Line: Human pancreatic carcinoma cell line (PANC-1) Concentration: 0.001, 0.1, 10, 1000 nM Incubation Time: Result: Augmented the inhibitory effects on HSP70 expression from 0.47 (Gemcitabine alone) to 0.13 (10 nM AFMK), 0.08 (0.1 nM AFMK) and 0.01 (0.001 nM AFMK). |
|---|
| In Vivo | AFMK is a potent antioxidant in vivo. AFMK significantly reverses radiation-induced decline in the total antioxidant capacity of plasma in mice[2]. Animal Model: Male C57BL mice 8 wk of age[2] Dosage: 10 mg/kg body weight Administration: Intraperitoneal injection Result: Radiation-induced decline in the total antioxidant capacity of plasma was significantly reversed in AFMK pretreated mice. AFMK-pretreated irradiated groups showed a significantly lower value of comet tail length and % DNA in tail. |
|---|
| References | [1]. Annia Galano, et al. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res. 2013 Apr;54(3):245-57. [2]. Kailash Manda, et al. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res. 2007 Apr;42(4):386-93. [3]. Anna Leja-Szpak, et al. Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1). Pharmacol Rep. 2018 Dec;70(6):1079-1088. |
|---|
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|
| Boiling Point | 589.4±50.0 °C at 760 mmHg |
|---|
| Melting Point | 138-140ºC |
|---|
| Molecular Formula | C13H16N2O4 |
|---|
| Molecular Weight | 264.277 |
|---|
| Flash Point | 310.3±30.1 °C |
|---|
| Exact Mass | 264.110992 |
|---|
| PSA | 84.50000 |
|---|
| LogP | 0.82 |
|---|
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
|---|
| Index of Refraction | 1.560 |
|---|
| InChIKey | JYWNYMJKURVPFH-UHFFFAOYSA-N |
|---|
| SMILES | COc1ccc(NC=O)c(C(=O)CCNC(C)=O)c1 |
|---|
| Storage condition | -20°C |
|---|
Safety Information
| Risk Phrases | R25 |
|---|
| Safety Phrases | 45 |
|---|
| RIDADR | UN 2811 6.1/PG 3 |
|---|
| HS Code | 2924299090 |
|---|
Customs
| HS Code | 2924299090 |
|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|---|
Synonyms
| N-[3-(2-Formamido-5-methoxyphenyl)-3-oxopropyl]acetamide |
| Acetamide, N-[3-[2-(formylamino)-5-methoxyphenyl]-3-oxopropyl]- |